Inflammation and its relevance to psychiatry

Advances in Psychiatric Treatment

Volumn 14, Issue 4, 2008, Pages 248-255

  Cavanagh, Jonathan ^a,b   Mathias, Christopher ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIDEPRESSANT AGENT; CELL ADHESION MOLECULE; CLOMIPRAMINE; CORTICOTROPIN RELEASING FACTOR; DESIPRAMINE; ETANERCEPT; FLUOXETINE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR FACTOR; OMEGA 3 FATTY ACID; REBOXETINE; SEROTONIN TRANSPORTER; STAT5 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRYPTOPHAN; TUMOR NECROSIS FACTOR;

ACTIVE TRANSPORT; ACUTE CORONARY SYNDROME; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD BRAIN BARRIER; CARDIOVASCULAR DISEASE; CAUSAL ATTRIBUTION; DEPRESSION; DISEASE ASSOCIATION; DRUG MECHANISM; HEART DEATH; HEPATITIS C; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; IMMUNOTHERAPY; INFLAMMATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; TRYPTOPHAN METABOLISM;

EID: 58049084106     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.bp.106.003319     Document Type: Article

References (37)

1. Anisman, H. & Merali, Z. (2002) Cytokines, stress and depressive illness. Brain, Behavior, and Immunity, 16, 513-524.
2. Bret-Dibat, J. L., Bluthe, R. M., Kent, S., et al (1995) Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism. Brain, Behavior, and Immunity, 9, 242-246.
3. Burke, H. M., Davis, M. C., Otte, C., et al (2005) Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology, 30, 846-856.
4. Capuron, L., Gumnick, J. F., Musselman, D. L., et al (2002a) Neurobehavioural effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology, 26, 643-652.
5. Capuron, L., Hauser, P., Hinze-Selch, D., et al, 2002b) Treatment of cytokine-induced depression. Brain, Behavior, and Immunity, 16, 575-580.
6. Dantzer, R., Konsman, J. P., Bluthe, R. M., et al (2000) Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Autonomic Neuroscience, 85, 60-65.
7. De Jonge, P., van den Brink, R. H. S., Spijkerman, T. A., et al (2006) Only incident depressive episodes after MI are associated with new cardiovascular events. Journal of the American College of Cardiology, 48, 2204-2208.
8. Empana, J. P., Sykes, D. H., Luc, G., et al (2005) Contributions of depressed mood and circulating inflammatory markers to coronary heart disease in healthy European men: PRIME. Circulation, 111, 2299-2305.
9. Frasure-Smith, N., Lespérance, F. & Talajic, M. (1993) Depression following MI. Impact on 6-month survival. JAMA, 270, 1819-1825.
10. Frasure-Smith, N., Lespérance, F., Irwin, M. R., et al (2007) Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndrome. Biological Psychiatry, 62, 302-308.
11. Glassman, A. H., Bigger, J. T., Gaffney, M., et al (2006) Onset of major depression associated with acute coronary syndromes. Archives of General Psychiatry, 63, 283-288.
12. Grace, S. L., Abbey, S. E., Kapral, M. K., et al (2005) Effect of depression on five-year mortality after an acute coronary syndrome. American Journal of Cardiology, 96, 1179-1185.
13. Himmerich, H., Binder, E. B., Kunzal, H. E., et al (2006) Successful antidepressant therapy restores the disturbed interplay between the TNF-alpha system and the HPA axis. Biological Psychiatry, 60, 882-888.
14. Kaneko, N., Kudo, K., Mabuchi, T., et al (2006) Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus. Neuropsychopharmacology, 31, 2619-2625.
15. Kent, S., Bret-Dibat, J. L., Kelley, K. W., et al (1996) Mechanisms of sickness-induced decreases in food-motivated behavior. Neuroscience and Biobehavioral Reviews, 20, 171-175.
16. Kohut, M. L., McCann, D. A., Russell, D. W., et al (2005) Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP and IL-6 independent of β-blockers, BMI and psychosocial factors in older adults. Brain, Behavior, and Immunity, 20, 201-209.
17. Ladwig, K. H., Marten-Mittag, B., Lowel, H., et al (2005) C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998. European Heart Journal, 26, 2537-2542.
18. Lauzon, C., Beck, C. A., Huynh, T., et al (2003) Depression and prognosis following hospital admission because of acute myocardial infarction. Canadian Medical Association Journal, 168, 547-552.
19. Lespérance, F., Frasure-Smith, N., Théroux P, et al (2004) The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6 and C-reactive protein in patients with recent acute coronary syndromes. American Journal of Psychiatry, 161, 271-277.
20. Maes, M. (1995) Evidence for an immune response in major depression: a review and hypothesis. Progress in Neuropsychopharmacology & Biological Psychiatry, 19, 11-38.
21. Mendlewicz, J., Kriwin, P., Oswald, P., et al (2006) Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. International Clinical Psychopharmacology, 21, 227-231.
22. Monje, M., Toda, H. & Palmer, T. D. (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science, 302, 1760-1765.
23. Mossner, R., Heils, A., Stober, G., et al (1998) Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6. Neurochemistry International, 33, 251-254.
24. Patten, S. B., Williams, J. V. & Wang, J. (2006) Mental disorders in a population sample with musculoskeletal disorders. BMC Musculoskeletal Disorders, 7, 37.
25. Raison, C. L., Capuron, L. & Miller, A. H. (2005) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology, 27, 24-31.
26. Raison, C. L., Borisov, A. S., Broadwell, S. D., et al (2006) Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. Journal of Clinical Psychiatry, 66, 41-48.
27. Rothwell, N. J. & Luheshi, G. N. (2000) Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends in Neurosciences, 23, 618-625.
28. Rumsfeld, J. S. & Ho, P. M. (2005) Depression and cardiovascular disease. A call for recognition. Circulation, 111, 250-253.
29. Schiepers, O. J., Wichers, M. C. & Maes, M. (2005) Cytokines and major depression. Progress in Neuro-psychopharmacology & Biological Psychiatry, 29, 201-217.
30. Tyring, S., Gottlieb, A., Papp, K., et al (2006) Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet, 367, 29-35.
31. Wann, B. P., Bah, T. M., Boucher, M., et al (2007) Vulnerability for apoptosis in the limbic system after myocardial infarction in rats: a possible model for human postinfarct major depression. Journal of Psychiatry and Neuroscience, 32, 11-16.
32. Welin, C., Lappas, G. & Wilhelmsen, L. (2000) Independent importance of psychosocial factors for prognosis after myocardial infarction. Journal of Internal Medicine, 247, 629-639.
33. Wichers, M. C., Koek, G. H., Robaeys, G., et al (2005) IDO and interferon alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Molecular Psychiatry, 10, 538-544.
34. World Health Organization (2001) The World Health Report 2001 - Mental Health: New Understanding, New Hope. WHO.
35. Yirmiya, R. (2000) Depression in medical illness: the role of the immune system. Western Journal of Medicine, 173, 333-336.
36. Zhu, C. B., Carneiro, A. M., Dostmann, W. R., et al (2005) p38 MAPK activation elevates serotonin transport activity via trafficking-independent, protein phosphatase 2A-dependent process. Journal of Biological Chemistry, 280, 15 649-15 658.
37. Zorrilla, E. P., Luborsky, L., McKay, J. R., et al (2001) The relationship of depression and stressors to immunological assays: a meta-analytical review. Brain, Behavior, and Immunity, 15, 199-226.